Processa Pharmaceuticals, Inc.
PCSA· Nasdaq
PCSAProcessa Pharmaceuticals, Inc.
Filed Mar 27, 2014 · 10-K · 86 days after period end · 0001393905-14-000131
derived · Computed from the longer spans the company filed.
| Metric | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures |
|---|---|---|
| Revenue | $70.09K | — |
| Net Income | -$806.93K | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Processa Pharmaceuticals, Inc. · CIK 1533743 · Engraved from SEC EDGAR
ended Dec 31, 2013 · filed Mar 27, 2014 · 86 d after period end
